BIBLIOGRAPHIC RECORD
A phase 2 uncontrolled, open-label study of intranasal BPL-003 (5-methoxy-<i>N,N</i>-dimethyltryptamine) in patients with treatment-resistant depression.
This record contains bibliographic metadata. Open the linked source to check the work; the record does not include its full text.
- Recorded authors
- Claire Roberts; Mathieu Seynaeve; Anna O Ermakova; Fiona Dunbar; Hattie Wells; Adeep Puri; Catherine Bird; James J Rucker
- Source of metadata
- PubMed
- Year recorded
- 2026
Public identifiers and source
Open the source recordReference
Claire Roberts; Mathieu Seynaeve; Anna O Ermakova; Fiona Dunbar; Hattie Wells; Adeep Puri; Catherine Bird; James J Rucker. (2026). A phase 2 uncontrolled, open-label study of intranasal BPL-003 (5-methoxy-<i>N,N</i>-dimethyltryptamine) in patients with treatment-resistant depression. https://pubmed.ncbi.nlm.nih.gov/41761045/
Reference assembled from the available metadata. Check and cite the original publication before reusing a claim.
Permanent record URL: https://brain.psiconautica.org/en/documentos/d-ea695a0065580dff4ef52b4aae2adaf0/